Is CytoMed Therapeutics Limited (GDTC) a Buy, Sell, or Hold?
NASDAQ : GDTC
CytoMed Therapeutics Limited
$1.02 USD
$0 (0.0%)
- Volume
- 2.64K
- Average Volume
- 19.16K
- Market Capitalization
- $12.07M
- P/E Ratio
- -3.25
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.68
- Year Low
- $0.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.17
GDTC Analyst Forecasts
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2025-06-30 | 1 | -99540 | -99540 | -99540 | -99540 | -99540 | -99540 |
| 2025-03-31 | 1 | -105.04K | -105.04K | -105.04K | -105.04K | -105.04K | -105.04K |
| 2024-06-30 | 1 | -126.86K | -126.86K | -126.86K | -126.86K | -126.86K | -126.86K |
| 2024-03-30 | 1 | -93600 | -93600 | -93600 | -93600 | -93600 | -93600 |
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2025-06-30 | 1 | -601.77K | -601.77K | -601.77K | 1.09M | 1.09M | 1.09M |
| 2025-03-31 | 1 | -635.01K | -635.01K | -635.01K | 1.15M | 1.15M | 1.15M |
| 2024-06-30 | 1 | -479.32K | -479.32K | -479.32K | 1.39M | 1.39M | 1.39M |
| 2024-03-30 | 1 | -354.28K | -354.28K | -354.28K | 1.07M | 1.07M | 1.07M |
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2025-06-30 | 1 | 165.9K | 165.9K | 165.9K | 1 | -0.0510464 | -0.0510464 | -0.0510464 |
| 2025-03-31 | 1 | 175.06K | 175.06K | 175.06K | 1 | -0.0538656 | -0.0538656 | -0.0538656 |
| 2024-06-30 | 1 | 211.43K | 211.43K | 211.43K | 1 | -0.040659 | -0.040659 | -0.040659 |
| 2024-03-30 | 1 | 156K | 156K | 156K | 1 | -0.03 | -0.03 | -0.03 |